Latest Hematological malignancy Stories
WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound under development for treating patients with high-risk myelodysplastic syndrome (MDS). In an announcement made this week, European commercial rights for rigosertib have been licensed to Baxter International providing significant resources to advance the program toward U.S. and...
CAMBRIDGE, Mass., Sept. 20, 2012 /PRNewswire/ -- Constellation Pharmaceuticals, Inc., a leading biopharmaceutical company in the field of epigenetics, today announced that it has entered into a strategic partnership with The Leukemia & Lymphoma Society® (LLS) to advance the development of a novel BET inhibitor for the treatment of patients with hematologic malignancies. Under the terms of the agreement, LLS will provide up to $7.5 million in funding to support Constellation's...
The Leukemia & Lymphoma Society Illinois Chapter (LLS) teams up with Fundinco.org to offer a unique fundraising option for their upcoming Light The Night Walk on October 20th and 21st in Chicagoland and Rockford. Chicago, IL (PRWEB) August 29, 2012 Fundinco.org and The Leukemia & Lymphoma Society are teaming up to offer a unique new fundraiser that allows Light The Night Walk teams to raise funds without soliciting for direct donations. Instead, supporters simply shop online and a...
WHITE PLAINS, N.Y., Aug. 23, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society is committed to bringing the most current information about blood cancers to all patients and is pleased to announce a unique educational opportunity for Spanish- and Portuguese-speaking patients with non-Hodgkin lymphoma (NHL) or chronic lymphocytic leukemia (CLL) and their families. On Thursday, September 13 from 1:00 to 2:30 PM Eastern Time, Dr. Christopher R. Flowers from the Winship Cancer...
SAN FRANCISCO, Aug. 9, 2012 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) is pleased to announce that America's Cup champions Ted Turner and Gary Jobson will attend the seventh annual Leukemia Cup Regatta weekend, October 20-21, 2012. Hosted by The San Francisco Yacht Club (SFYC) in Belvedere, CA, the Leukemia Cup Regatta supports LLS' mission to find a cure for leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life for patients and...
ATLANTA, Aug. 1, 2012 /PRNewswire/ -- Global Franchise Group, the strategic brand management company, is pleased to announce their partnership with The Leukemia & Lymphoma Society (LLS) for fundraising efforts beginning on August 1st through September 30th. The company has set a goal of raising $200,000 during their partnership period. The Global Franchise Group family of brands includes Great American Cookies®, Marble Slab Creamery®, MaggieMoo's Ice Cream & Treatery®,...
There’s still time for both men and women to sign up for the San Francisco Nike Women’s Marathon with the Bay Area Chapter of the Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT), which recently found out what motivates men to participate in the popular race. San Francisco, CA (PRWEB) July 15, 2012 The San Francisco Nike Women’s Marathon is not just for women. Although the majority of the 20,000 runners who participate every year are female, the Leukemia &...
MPN Research Foundation and The Leukemia & Lymphoma Society Partner to Fund Concept Grants Chicago, IL & White Plains, NY (PRWEB) July 11, 2012 The MPN Research Foundation and the Leukemia & Lymphoma Society are proud to announce the winners of the MF Challenge. Winners of these one year concept grants focusing on fibrosis and myelofibrosis are: Ann Mullaly & Benjamin L. Ebert, of Brigham & Women’s Hospital Amit Verma and Zhizhuang Joe Zhao, of the Albert...
WHITE PLAINS, N.Y., July 9, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society's (LLS) 2012 Man & Woman of the Year campaign exceeded last year's record-breaking year, raising $18.9 million for blood cancer research and patient services. In its 22nd year more than 800 candidates participated and surpassed last year's fundraising record by $4.2 million. Out of all those candidates, one man, Washington D.C. leukemia survivor Tommy Cleaver, and one woman, St. Louis based...
WHITE PLAINS, N.Y. and PRINCETON, N.J., July 2, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society® (LLS) and Celator Pharmaceuticals, Inc. today announced a significant expansion of their partnership to support clinical development and potential registration of Celator's lead product candidate CPX-351 (Cytarabine:Daunorubicin) Liposome Injection for treatment of adults with acute myeloid leukemia (AML). Under the new agreement, LLS will provide $5 million in funding,...
